Nicholas Bodor

1.0k total citations
53 papers, 739 citations indexed

About

Nicholas Bodor is a scholar working on Organic Chemistry, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Nicholas Bodor has authored 53 papers receiving a total of 739 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Organic Chemistry, 17 papers in Molecular Biology and 8 papers in Pharmaceutical Science. Recurrent topics in Nicholas Bodor's work include Free Radicals and Antioxidants (6 papers), Computational Drug Discovery Methods (6 papers) and Estrogen and related hormone effects (5 papers). Nicholas Bodor is often cited by papers focused on Free Radicals and Antioxidants (6 papers), Computational Drug Discovery Methods (6 papers) and Estrogen and related hormone effects (5 papers). Nicholas Bodor collaborates with scholars based in United States, Hungary and Iceland. Nicholas Bodor's co-authors include Péter Buchwald, Marcus E. Brewster, James W. Simpkins, Þorsteinn Loftsson, Kerry Estes, James J. Kaminski, Wesley R. Anderson, Warren C. Stern, Maninder Hora and Whei‐Mei Wu and has published in prestigious journals such as Journal of the American Chemical Society, The Journal of Physical Chemistry B and Journal of Medicinal Chemistry.

In The Last Decade

Nicholas Bodor

51 papers receiving 699 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicholas Bodor United States 17 235 137 131 100 92 53 739
Emil Pop United States 17 401 1.7× 135 1.0× 348 2.7× 65 0.7× 106 1.2× 122 1.1k
Randall R. Miller United States 18 409 1.7× 40 0.3× 120 0.9× 68 0.7× 80 0.9× 27 905
Henry Guzik United States 17 362 1.5× 55 0.4× 333 2.5× 39 0.4× 34 0.4× 31 844
Wesley R. Anderson United States 16 153 0.7× 107 0.8× 44 0.3× 25 0.3× 44 0.5× 38 535
P.M. Woollard United Kingdom 19 403 1.7× 44 0.3× 276 2.1× 38 0.4× 56 0.6× 25 1.2k
Bruce W. Surber United States 17 359 1.5× 51 0.4× 242 1.8× 43 0.4× 73 0.8× 36 1.2k
Richard Svensson Sweden 18 491 2.1× 35 0.3× 210 1.6× 77 0.8× 83 0.9× 42 1.1k
Hassan H. Farag Egypt 20 313 1.3× 58 0.4× 517 3.9× 104 1.0× 56 0.6× 43 1.0k
A. Michael Crider United States 17 378 1.6× 48 0.4× 542 4.1× 63 0.6× 89 1.0× 55 1.0k
Graham A. Showell United Kingdom 18 474 2.0× 76 0.6× 913 7.0× 64 0.6× 47 0.5× 34 1.4k

Countries citing papers authored by Nicholas Bodor

Since Specialization
Citations

This map shows the geographic impact of Nicholas Bodor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas Bodor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas Bodor more than expected).

Fields of papers citing papers by Nicholas Bodor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas Bodor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas Bodor. The network helps show where Nicholas Bodor may publish in the future.

Co-authorship network of co-authors of Nicholas Bodor

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas Bodor. A scholar is included among the top collaborators of Nicholas Bodor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas Bodor. Nicholas Bodor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Horváth, Gy., et al.. (2004). Etiprednol dicloacetate, a new soft glucocorticoid drug candidate. Development of chemistry.. PubMed. 59(5). 349–59. 1 indexed citations
2.
Yoon, Sung‐Hwa, Jiaxiang Wu, Whei‐Mei Wu, László Prókai, & Nicholas Bodor. (2000). Brain-targeted chemical delivery of [Leu2, Pip3]-TRH. Bioorganic & Medicinal Chemistry. 8(5). 1059–1063. 5 indexed citations
3.
Bodor, Nicholas, et al.. (1999). Soft Drugs Based on Hydrocortisone: The Inactive Metabolite Approach and Its Application to Steroidal Antiinflammatory Agents. Pharmaceutical Research. 16(6). 961–967. 11 indexed citations
4.
Bodor, Nicholas & Péter Buchwald. (1998). All in the mind. 34(1). 36–40. 38 indexed citations
5.
Wu, Whei‐Mei, et al.. (1996). Design, Synthesis, and Pharmacokinetic Evaluation of a Chemical Delivery System for Drug Targeting to Lung Tissue. Journal of Pharmaceutical Sciences. 85(5). 496–504. 14 indexed citations
6.
Brewster, Marcus E., Pascal Druzgala, Wesley R. Anderson, et al.. (1995). Efficacy of a 3‐Substituted Versus 17‐Substituted Chemical Delivery System for Estradiol Brain Targeting. Journal of Pharmaceutical Sciences. 84(1). 38–43. 5 indexed citations
7.
Bodor, Nicholas. (1995). Targeting Drugs to the Brain by Sequential Metabolism. PsycEXTRA Dataset. 147. 1–32. 5 indexed citations
8.
Bodor, Nicholas. (1994). Designing Safer Ophthalmic Drugs by Soft Drug Approaches. Journal of Ocular Pharmacology and Therapeutics. 10(1). 3–15. 20 indexed citations
9.
Bodor, Nicholas, et al.. (1993). Design and delivery of ophthalmic drugs : chemical approaches.. Indian Journal of Pharmaceutical Sciences. 55(5). 1 indexed citations
10.
Pop, Emil, Marcus E. Brewster, Wesley R. Anderson, & Nicholas Bodor. (1993). ChemInform Abstract: Biodistribution of Azidothymidine Mediated by a Highly Lipophilic Chemical Delivery System.. ChemInform. 24(28). 2 indexed citations
11.
Bodor, Nicholas, et al.. (1992). A comparison of intraocular pressure elevating activity of loteprednol etabonate and dexamethasone in rabbits. Current Eye Research. 11(6). 525–530. 30 indexed citations
12.
Brewster, Marcus E. & Nicholas Bodor. (1992). Redox Approaches to Drug Delivery to the Central Nervous System. PsycEXTRA Dataset. 120. 169–201. 7 indexed citations
13.
Raghavan, Krishnaswamy, Þorsteinn Loftsson, Marcus E. Brewster, & Nicholas Bodor. (1992). Improved Delivery Through Biological Membranes. XLV. Synthesis, Physical-Chemical Evaluation, and Brain Uptake Studies of 2-Chloroethyl Nitrosourea Delivery Systems. Pharmaceutical Research. 9(6). 743–749. 12 indexed citations
14.
Druzgala, Pascal, et al.. (1992). New Water-Soluble Pilocarpine Derivatives with Enhanced and Sustained Muscarinic Activity. Pharmaceutical Research. 9(3). 372–377. 13 indexed citations
15.
Brewster, Marcus E., et al.. (1990). Improved delivery through biological membranes. 36. Extension of a redox-based chemical-delivery system to .alpha.,.beta.-unsaturated ketones. Journal of Medicinal Chemistry. 33(8). 2063–2065. 3 indexed citations
16.
Anderson, Wesley R., et al.. (1989). Effects of a Brain-Enhanced Chemical Delivery System for Estradiol on Body Weight and Food Intake in Intact and Ovariectomized Rats. Pharmaceutical Research. 6(7). 592–600. 18 indexed citations
17.
Phelan, Michael & Nicholas Bodor. (1989). Improved Delivery Through Biological Membranes. XXXVII. Synthesis and Stability of Novel Redox Derivatives of Naproxen and Indomethacin. Pharmaceutical Research. 6(8). 667–676. 11 indexed citations
18.
Anderson, Wesley R., et al.. (1988). Evidence for suppression of serum LH without elevation in serum estradiol or prolactin with a brain-enhanced redox delivery system for estradiol. Life Sciences. 42(16). 1493–1502. 16 indexed citations
19.
Stacpoole, Peter W., Miguel González, Jirina Vlasak, Yasuo Oshiro, & Nicholas Bodor. (1987). Dichloroacetate derivatives. metabolic effects and pharmacodynamics in normal rats. Life Sciences. 41(18). 2167–2176. 9 indexed citations
20.
Bodor, Nicholas, et al.. (1980). Resolution of chiral phosphamides. Journal of the American Chemical Society. 102(11). 3969–3971. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emil Pop Breakdown of academic impact, for papers by Randall R. Miller Breakdown of academic impact, for papers by Henry Guzik Breakdown of academic impact, for papers by Wesley R. Anderson Breakdown of academic impact, for papers by P.M. Woollard Breakdown of academic impact, for papers by Bruce W. Surber Breakdown of academic impact, for papers by Richard Svensson Breakdown of academic impact, for papers by Hassan H. Farag Breakdown of academic impact, for papers by A. Michael Crider Breakdown of academic impact, for papers by Graham A. Showell
Rankless by CCL
2026